Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 23

1.

Prospective phase II trial of neoadjuvant chemotherapy with gemcitabine and cisplatin for resectable adenocarcinoma of the pancreatic head.

Heinrich S, Pestalozzi BC, Schäfer M, Weber A, Bauerfeind P, Knuth A, Clavien PA.

J Clin Oncol. 2008 May 20;26(15):2526-31. doi: 10.1200/JCO.2007.15.5556.

PMID:
18487569
2.

Neoadjuvant/preoperative gemcitabine for patients with localized pancreatic cancer: a meta-analysis of prospective studies.

Andriulli A, Festa V, Botteri E, Valvano MR, Koch M, Bassi C, Maisonneuve P, Sebastiano PD.

Ann Surg Oncol. 2012 May;19(5):1644-62. doi: 10.1245/s10434-011-2110-8. Epub 2011 Oct 20. Review.

PMID:
22012027
3.

Novel directions in neoadjuvant therapy for pancreas adenocarcinoma.

Yang A, O'Reilly EM.

Expert Rev Gastroenterol Hepatol. 2015 May;9(5):585-601. doi: 10.1586/17474124.2015.1012496. Epub 2015 Feb 16. Review.

PMID:
25686370
4.

Advances in non-operative therapy in pancreatic cancer.

Brammer R, Buckels J, Bramhall S.

Int J Clin Pract. 2000 Jul-Aug;54(6):373-81. Review.

PMID:
11092111
5.

Current standards and new innovative approaches for treatment of pancreatic cancer.

Conroy T, Bachet JB, Ayav A, Huguet F, Lambert A, Caramella C, Maréchal R, Van Laethem JL, Ducreux M.

Eur J Cancer. 2016 Apr;57:10-22. doi: 10.1016/j.ejca.2015.12.026. Epub 2016 Feb 4. Review.

PMID:
26851397
6.

Perioperative Therapy for Surgically Resectable Pancreatic Adenocarcinoma.

Du L, DeFoe M, Ruzinova MB, Olsen JR, Wang-Gillam A.

Hematol Oncol Clin North Am. 2015 Aug;29(4):717-26. doi: 10.1016/j.hoc.2015.04.011. Epub 2015 May 30. Review.

7.

[A case of pancreatic cancer with local recurrence and liver metastases eight years after surgery].

Taniguchi H, Mizuma M, Motoi F, Abe T, Okada R, Kawaguchi K, Karasawa H, Masuda K, Yabuuchi S, Fukase K, Sakata N, Okada T, Nakagawa K, Hayashi H, Morikawa T, Yoshida H, Naito T, Katayose Y, Egawa S, Unno M.

Gan To Kagaku Ryoho. 2014 Nov;41(12):2193-5. Review. Japanese.

PMID:
25731467
8.
9.

Neoadjuvant therapy in pancreatic adenocarcinoma: a meta-analysis of phase II trials.

Assifi MM, Lu X, Eibl G, Reber HA, Li G, Hines OJ.

Surgery. 2011 Sep;150(3):466-73. doi: 10.1016/j.surg.2011.07.006. Review.

10.

Borderline resectable pancreatic cancer: on the edge of survival.

Springett GM, Hoffe SE.

Cancer Control. 2008 Oct;15(4):295-307. Review.

11.

Long-term recurrence-free survival in a patient with pancreatic carcinosarcoma: a case report with a literature review.

Zhu WY, Liu TG, Zhu H.

Med Oncol. 2012 Mar;29(1):140-3. doi: 10.1007/s12032-010-9804-9. Epub 2011 Jan 25. Review.

PMID:
21264541
12.

Pancreatic adenocarcinoma: treating a systemic disease with systemic therapy.

Sohal DP, Walsh RM, Ramanathan RK, Khorana AA.

J Natl Cancer Inst. 2014 Mar;106(3):dju011. doi: 10.1093/jnci/dju011. Epub 2014 Feb 22. Review.

PMID:
24563516
13.

[Current diagnosis and treatment of pancreatic cancer].

Heinrich S, Schäfer M, Bauerfeind P, Pestalozzi BC, Clavien PA.

Praxis (Bern 1994). 2005 Aug 17;94(33):1243-54. Review. German.

PMID:
16138769
14.

Neoadjuvant therapy for patients with borderline resectable pancreatic cancer: A systematic review and meta-analysis of response and resection percentages.

Tang K, Lu W, Qin W, Wu Y.

Pancreatology. 2016 Jan-Feb;16(1):28-37. doi: 10.1016/j.pan.2015.11.007. Epub 2015 Dec 2. Review.

PMID:
26687001
15.

A neoadjuvant strategy for the management of nonmetastatic pancreatic cancer.

Goff SL, Chabot JA.

Cancer J. 2012 Nov-Dec;18(6):602-8. doi: 10.1097/PPO.0b013e318279aade. Review.

PMID:
23187848
16.

[Pancreatic adenocarcinoma: 10 years of progress].

Hammel P, Neuzillet C, Bendaoud S, Lekhal C, de Mestier L, Hentic O.

Bull Cancer. 2015 Jun;102(6 Suppl 1):S62-71. doi: 10.1016/S0007-4551(15)31219-4. Review. French.

PMID:
26118879
17.

Pancreatic cancer-improved care achievable.

Buanes TA.

World J Gastroenterol. 2014 Aug 14;20(30):10405-18. doi: 10.3748/wjg.v20.i30.10405. Review.

18.

Adjuvant and neoadjuvant therapies in resectable pancreatic cancer: a systematic review of randomized controlled trials.

D'Angelo FA, Antolino L, La Rocca M, Petrucciani N, Magistri P, Aurello P, Ramacciato G.

Med Oncol. 2016 Mar;33(3):28. doi: 10.1007/s12032-016-0742-z. Epub 2016 Feb 17. Review.

PMID:
26883935
19.

Current Systemic Treatment and Emerging Therapeutic Strategies in Pancreatic Adenocarcinoma.

Yee NS, Kazi AA, Yee RK.

Curr Clin Pharmacol. 2015;10(4):256-66. Review.

PMID:
26548903
20.

Neoadjuvant treatment in pancreatic cancer: Evidence-based medicine? A systematic review and meta-analysis.

D'Angelo F, Antolino L, Farcomeni A, Sirimarco D, Kazemi Nava A, De Siena M, Petrucciani N, Nigri G, Valabrega S, Aurello P, Ramacciato G.

Med Oncol. 2017 May;34(5):85. doi: 10.1007/s12032-017-0951-0. Epub 2017 Apr 8. Review.

PMID:
28391577

Supplemental Content

Support Center